Position in BHC
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,342,534
+$1,891,978 QoQ
Shares Held
880,839
+94.1% QoQ
Ownership
0.236%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 220 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $2,415,050,910 across 61 Drug Manufacturers - Specialty & Generic names. BHC ranks #26 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
6,398,674 | $1,078,432,506 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,981,234 | $236,524,202 | |
| 3 | ZTS |
Zoetis Inc.
|
2,624,825 | $188,619,917 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
4,766,781 | $165,264,292 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
275,358 | $149,197,220 | |
| 6 | VTRS |
Viatris Inc
|
7,322,267 | $116,277,595 | |
| 7 | HLN |
Haleon plc
|
10,824,395 | $100,991,599 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
699,229 | $77,572,458 |
All Filings in BHC
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,342,534 | 880,839 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,450,556 | 453,807 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,762,797 | 253,640 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,578,817 | 244,778 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $3,245,990 | 487,386 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,191,119 | 184,099 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $159,909 | 19,840 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $12,027 | 1,474 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $10,273 | 1,474 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $664,513 | 62,631 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $2,321,540 | 289,469 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $438,215 | 53,311 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $428,088 | 53,511 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $415,294 | 51,271 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $287,918 | 45,847 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,974,275 | 1,012,232 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $24,220,496 | 2,897,189 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $39,111,108 | 1,711,646 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $47,237,891 | 1,710,898 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $45,220,238 | 1,623,707 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $56,811,894 | 1,937,650 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $42,551,530 | 1,340,628 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $27,798,948 | 1,336,488 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $19,726,379 | 1,269,394 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $18,679,903 | 1,021,318 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $17,901,259 | 1,154,920 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||